| Neuroinflammation in Cerebral Ischemia and Ischemia/Reperfusion Injuries: From Pathophysiology to Therapeutic Strategies A Jurcau, A Simion International Journal of Molecular Sciences 23 (1), 14, 2021 | 290 | 2021 |
| Oxidative stress in ischemia/reperfusion injuries following acute ischemic stroke A Jurcau, AI Ardelean Biomedicines 10 (3), 574, 2022 | 96 | 2022 |
| Molecular mechanisms of neuroinflammation in aging and Alzheimer’s disease progression FL Andronie-Cioara, AI Ardelean, CD Nistor-Cseppento, A Jurcau, ... International journal of molecular sciences 24 (3), 1869, 2023 | 83 | 2023 |
| Insights into the pathogenesis of neurodegenerative diseases: Focus on mitochondrial dysfunction and oxidative stress A Jurcau International journal of molecular sciences 22 (21), 11847, 2021 | 82 | 2021 |
| Molecular pathophysiological mechanisms of ischemia/reperfusion injuries after recanalization therapy for acute ischemic stroke A Jurcau, IA Ardelean Journal of integrative neuroscience 20 (3), 727-744, 2021 | 70 | 2021 |
| Molecular pathophysiological mechanisms in Huntington’s disease A Jurcau Biomedicines 10 (6), 1432, 2022 | 69 | 2022 |
| The link between oxidative stress, mitochondrial dysfunction and neuroinflammation in the pathophysiology of Alzheimer’s disease: therapeutic implications and future perspectives MC Jurcău, FL Andronie-Cioara, A Jurcău, F Marcu, DM Ţiț, N Pașcalău, ... Antioxidants 11 (11), 2167, 2022 | 52 | 2022 |
| The Role of Natural Antioxidants in the Prevention of Dementia—Where Do We Stand and Future Perspectives A JURCAU NUTRIENTS, 2021 | 42 | 2021 |
| Oxidative stress in the pathogenesis of Alzheimer’s disease and cerebrovascular disease with therapeutic implications A Jurcau, A Simion CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2020 | 41 | 2020 |
| The contribution of diet therapy and probiotics in the treatment of sarcopenia induced by prolonged immobilization caused by the COVID-19 pandemic CD Nistor-Cseppento, TD Moga, AF Bungau, DM Tit, N Negrut, B Pasca, ... Nutrients 14 (21), 4701, 2022 | 31 | 2022 |
| The involvement of neuroinflammation in the onset and progression of Parkinson’s disease A Jurcau, FL Andronie-Cioara, DC Nistor-Cseppento, N Pascalau, M Rus, ... International Journal of Molecular Sciences 24 (19), 14582, 2023 | 26 | 2023 |
| Mitochondria in Huntington’s disease: implications in pathogenesis and mitochondrial-targeted therapeutic strategies A Jurcau, CM Jurcau Neural Regeneration Research 18 (7), 1472-1477, 2023 | 26 | 2023 |
| Therapeutic strategies in Huntington’s disease: From genetic defect to gene therapy A Jurcau, MC Jurcau Biomedicines 10 (8), 1895, 2022 | 26 | 2022 |
| The role of antioxidant treatment in acute ischemic stroke: Past, present and future A Simion, A Jurcau Neurol. Res. Surg 2, 1-7, 2019 | 25 | 2019 |
| Stem cell-and cell-based therapies for ischemic stroke DC Nistor-Cseppentö, MC Jurcău, A Jurcău, FL Andronie-Cioară, F Marcu Bioengineering 9 (11), 717, 2022 | 18 | 2022 |
| Cognition, statins, and cholesterol in elderly ischemic stroke patients: A neurologist’s perspective A Jurcau, A Simion Medicina 57 (6), 616, 2021 | 17 | 2021 |
| Acute cerebral ischemia and oxidative stress A Jurcau Romanian journal of Neurology 2 (2), 45-56, 2008 | 14 | 2008 |
| THE ROLE OF ANTIOXIDANT TREATMENT IN ACUTE ISCHEMIC STROKE: A CLINICAL STUDY. A Jurcau Romanian Journal of Neurology 6 (4), 2007 | 10 | 2007 |
| Usefulness of the Edmonton Frail Scale in assessing the impact of heart failure on frailty DC Iovanovici, AG Negru, CDN Cseppento, CF Bochis, BG Dogaru, ... in vivo 37 (4), 1857-1866, 2023 | 8 | 2023 |
| Tau-targeted therapies in Alzheimer's disease - history and current state A Jurcau, VS Nunkoo Frontiers in Clinical Drug Research - Dementia 2, 56-139, 2021 | 8* | 2021 |
